Differences/NNS
in/IN
phosphorylation/NN
of/IN
the/DT
IL-2R/NN
associated/JJ
JAK/STAT/NN
proteins/NNS
between/IN
HTLV-I(+)/JJ
,/,
IL-2-independent/JJ
and/CC
IL-2-dependent/JJ
cell/NN
lines/NNS
and/CC
uncultured/JJ
leukemic/JJ
cells/NNS
from/IN
patients/NNS
with/IN
adult/JJ
T-cell/NN
lymphoma/leukemia/NN
./.

To/TO
determine/VB
activation/NN
status/NN
of/IN
the/DT
IL-2R-associated/JJ
(/(
Jak/STAT/NN
)/)
pathway/NN
in/IN
the/DT
HTLV-I/NN
infected/JJ
cells/NNS
,/,
we/PRP
examined/VBD
tyrosine/NN
phosphorylation/NN
of/IN
Jak3/NN
,/,
STAT3/NN
,/,
and/CC
STAT5/NN
in/IN
several/JJ
HTLV-I(+)/JJ
T-cell/NN
lines/NNS
and/CC
in/IN
uncultured/JJ
leukemic/JJ
T/NN
cells/NNS
isolated/VBN
from/IN
patients/NNS
with/IN
adult/JJ
T-cell/NN
lymphoma/leukemia/NN
(/(
ATLL/NN
)/)
./.
=====
Constitutive/JJ
basal/JJ
phosphorylation/NN
of/IN
Jak3/NN
and/CC
,/,
usually/RB
,/,
STAT3/NN
and/CC
STAT5/NN
was/VBD
detected/VBN
in/IN
all/DT
four/CD
IL-2-independent/JJ
cell/NN
lines/NNS
tested/VBN
,/,
but/CC
in/IN
none/NN
of/IN
the/DT
three/CD
IL-2-dependent/JJ
cell/NN
lines/NNS
./.
=====
Similarly/RB
,/,
there/EX
was/VBD
no/DT
detectable/JJ
basal/JJ
phosphorylation/NN
of/IN
Jak3/NN
and/CC
STAT5/NN
in/IN
the/DT
leukemic/JJ
cells/NNS
from/IN
ATLL/NN
patients/NNS
(/(
0/8/CD
and/CC
0/3/CD
,/,
respectively/RB
)/)
./.
=====
However/RB
,/,
stimulation/NN
with/IN
IL-2/NN
resulted/VBD
in/IN
Jak3/NN
and/CC
STAT5/NN
phosphorylation/NN
in/IN
both/CC
leukemic/JJ
ATLL/NN
cells/NNS
and/CC
IL-2-dependent/JJ
lines/NNS
./.
=====
Furthermore/RB
,/,
expression/NN
of/IN
SHP-1/NN
phosphatase/NN
which/WDT
is/VBZ
a/DT
negative/JJ
regulator/NN
of/IN
cytokine/NN
receptor/NN
signaling/NN
,/,
was/VBD
lost/VBN
in/IN
most/JJS
IL-2/NN
independent/JJ
cell/NN
lines/NNS
(/(
3/4/CD
)/)
but/CC
not/RB
in/IN
the/DT
leukemic/JJ
ATLL/NN
cells/NNS
(/(
0/3/CD
)/)
./.
=====
Finally/RB
,/,
the/DT
HTLV-I(+)/JJ
T-cell/NN
lines/NNS
(/(
313/CD
)/)
but/CC
not/RB
the/DT
control/NN
,/,
HTLV-I(-)/JJ
T-cell/NN
lines/NNS
were/VBD
resistant/JJ
to/TO
rapamycin/NN
and/CC
its/PRP$
novel/JJ
analog/NN
RAD/NN
./.
=====
We/PRP
conclude/VBP
that/IN
(/(
1/LS
)/)
HTLV-I/NN
infection/NN
per/FW
se/FW
does/VBZ
not/RB
result/VB
in/IN
a/DT
constitutive/JJ
phosphorylation/NN
of/IN
the/DT
Jak3/NN
,/,
STAT3/NN
,/,
and/CC
STAT5/NN
proteins/NNS
;/:
(/(
2/LS
)/)
malignant/JJ
transformation/NN
in/IN
at/IN
least/JJS
some/DT
cases/NNS
of/IN
ATLL/NN
does/VBZ
not/RB
require/VB
the/DT
constitutive/JJ
,/,
but/CC
may/MD
require/VB
IL-2-induced/JJ
,/,
activation/NN
of/IN
the/DT
IL-2R/NN
Jak/STAT/NN
pathway/NN
;/:
and/CC
(/(
3/LS
)/)
there/EX
are/VBP
major/JJ
differences/NNS
in/IN
T-cell/NN
immortalization/NN
mechanism/NN
(/(
s/NNS
)/)
which/WDT
appear/VBP
to/TO
involve/VB
SHP-1/NN
and/CC
target/NN
molecules/NNS
for/IN
rapamycin/NN
and/CC
RAD/NN
./.